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Abstract  
An opportunistic infection is caused by variety of pathogens such as bacteria, virus, fungi or protozoans that usually do not 
cause disease in a healthy host. In order to accomplish the objectives of the present research work clinical samples were 
collected from debilitated patients. Out of 45 samples 27 were found to be positive for fungal infection. A total number of 76 
mold form and ample number of Candida spp. clinical isolates were obtained. The common molds isolated were Alternaria 
alternata, A. fumigatus, A. niger, A. terreus, A. nidulans, A. flavus, Rhizopus spp. Mucur spp. and Curvularia lunata. In order 
to study the antifungal profile of the clinical isolates in vitro antifungal susceptibility test was performed by Kirby Bauer Method. 
Ketoconazole was found to be most effective azole against the clinical isolates followed by Clotrimazole, Itraconazole  and 
Amphoterecin B. 
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INTRODUCTION 
 
     Mycosis (plural; Mycoses) is a condition in which fungi pass 
the resistance barriers of the human or animal body and establish 
infection. The incidence of invasive opportunistic mycoses has 
increased because of the expanding population of 
immunocompromised patients, including solid-organ transplant 
(SOT) and hematopoietic stem cell transplant (HSCT) recipients, 
patients with cancer, patients with AIDS, premature neonates, elderly 
patients, and patients recovering from major surgery [1, 2]. People 
are at risk of fungal infections when they are taking strong antibiotics 
for a long period. Opportunistic infections can occur all over the body 
and be relatively localized (affect only one part of the body) or 
systemic or disseminated (spread to other parts of the body and 
other body systems).  Opportunistic mycoses show distinct regional 
incidence patterns throughout the world and may exhibit different 
epidemiologic features, depending on the geographic region; this 
may be particularly true for mycoses (such as mold infections) that 
are acquired from the environment [3].  
     With the increasing incidents of fungal infections in 
immunocompromised and debilitated patients, the use of antifungal 
therapy for clinical purpose is demanding. The present work deals 
with the isolation of common fungi in immunocompromised patient 
and the study of their antifungal profile. The study will help in clinical 
therapy. The use of spices and herbs alone and in combination with 
synthetic drugs can be suggested for clinical outcomes. 
 
METHODOLOGY 
 
     The present research work deals with collection clinical 
samples from debilitated patients. The samples were subjected to 
direct microscopic observation and culture. In vitro antimicrobial 
activities were determined by the agar disc diffusion method (Dugler 
& Gonuz, 1997; Dugler et al., 2004). The disc diffusion method 
(antimicrobial susceptibility testing) is also known as Kirby – Bauer 
method being recommended by the NCCLS. The thermo tolerance 
test of the clinical fungal isolates was performed which is suggestive 
of their pathological nature. 
     A total number of 45 samples were collected from the diabetic 
patients from Jabalpur Hospital and Research Centre. The samples 
were collected in McCartney’s bottle from pathology department of 
Jabalpur Hospital and Research Centre. Then the clinical samples 
were subjected to direct microscopic observation and culture.  
 
RESULT AND DISCUSSION   
 
     Out of 45 samples 29 were found to be positive for fungal 
infection. The results are expressed in table no. 1 The samples were 
subjected to direct culture. The collected blood sample was spread 
on the SDA plates with Chloramphenicol @ 30mg/1000ml. The 
results obtained are shown in table no.2. The fungi (clinical isolates) 
were identified Macro morphological, Microscopic characteristics and 
biochemical tests. 
     The common spp. isolated from diabetic patients was 
common causal agents of opportunistic infections. From the table no. 
2 it is evident that the common spp. which causes opportunistic 
infection are Aspergillus, Alternaria, Candida, Curvularia, Rihzopus, 
and Mucur spp. 
     Thermotolerance test of clinical isolates were done at the 
temperature 28°C, 37°C and 45°C. The results are expressed in 
table no. 3.From the results it is evident that almost all clinical 
isolates have the potential to grow at high temperature identifying 
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their pathological nature. 
     Antifungal susceptibility test was performed for different 
clinical isolates by disk diffusion method (Kirby Bauer). Kirby Bauer 
method was suitable for routine testing in clinical laboratory where 
large number of isolates is served for susceptibility to numerous 
antibiotics. 
     The antifungal susceptibility exhibited by the clinical isolates is 
expressed in table no. 4 from the table it was evident that the clinical 
isolates were susceptible to the azoles used in the present study.
 
 
Table 1. Case History of Diabetic Patients 
 
  
   
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Results of direct culture: isolation and identification of Fungi 
  
S.No Patient id No. of Colonies Fungi Identified 
1 1 6 Alternaria alternata 
2 2 1 A. flavus 
3 4 Many Candida spp 
4 6 8 Rhizopus spp. 
5 7 5 A.fumigatus 
6 9 7 C. albicans 
7 11 6 A.terreus 
Patient ID Gender Sugar Level Presented Fungal Strain 
1 F 158 + 
2 M 256.6 - 
3 F 209 + 
4 M 132 + 
5 F 220 + 
6 F 140 - 
7 M 226 + 
8 F 192 - 
9 F 197 + 
10 F 189 + 
11 M 156 + 
12 F 123 + 
13 F 189 - 
14 M 156 - 
15 F 119 + 
16 M 125 + 
17 M 145 + 
18 M 189 + 
19 F 178 - 
20 M 214 + 
21 M 128 + 
22 F 148 + 
23 M 169 - 
24 F 186 - 
25 F 174 + 
26 F 210 + 
27 M 184 - 
28 M 178 - 
29 F 160 - 
30 M 182 + 
31 F 248 + 
32 M 212 + 
33 F 149 - 
34 M 145 + 
35 F 186 + 
36 M 125 - 
37 M 149 - 
38 F 210 + 
39 M 156 - 
40 F 181 + 
41 F 170 + 
42 M 198 + 
43 M 158 - 
44 F 221 + 
45 F 171 + 
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8 13 3 R.arrhyzus 
9 14 2 Curvularia lunata 
10 17 3      A.niger 
11 20 6      A.flavus 
12 21 2 Candida albicans 
13 22 2 Curvularia lunata 
14 23 2 Mucur spp. 
15 26 2            A.umigatus 
16 27 2 Alternaria alternata 
17 28 4 A. terreus 
18 31 2 A. niger 
19 32 3    A.nidulans 
20 33 2 Mucur spp. 
21 35 5 Rhizopus spp. 
22 38 7 Mucur spp. 
23 39 4 A.nidulans 
24 40 3             A.niger 
25 41 12 C. albicans 
26 43 3             A.niger 
27 44 7 C. albicans 
 
Table 3. Thermotolerance Test of Clinical Fungal Isolates 
 
Fungal Isolates Temperature 
28°C 37°C 45°C 
Alternaria alternata ++ + ++ 
Aspergillus fumigatus ++ ++ ++ 
A. niger +++ +++ +++ 
A. terreus ++ ++ ++ 
A. nidulans +++ ++ +++ 
Candida albicans ++ ++ ++ 
Rhizopus spp. +++ +++ +++ 
Rhizopus arrhyzus +++ +++ +++ 
Mucur spp. +++ +++ +++ 
Curvularia lunata ++ + +++ 
                     + : Less Growth, ++ : Moderate Growth, +++: Effluent Growth 
 
Table 4. Antifungal Susceptibility Test of Different Fungal Isolates 
 
 Fungal Isolates 
 
Antibiotics 
CC KT IT Amp.B. 
Alternaria alternata 2 cm. 3 cm. 2 cm. 1 cm. 
Aspergillus fumigatus 2 cm. 1.2 cm. 2 cm. 1 cm. 
A.niger 0.3 cm. 1.5 cm. 0.3 cm. 0.2 cm. 
A.terreus 1.4 cm. 1.9 cm. 1.5 cm. 1.5 cm. 
A.nidulans 1.4 cm. 1.8 cm. 1.3 cm. 0.1 cm. 
Aspergillus flavus 0.06 cm. 1.18 cm. 1.28 cm. 0.6 cm. 
Candida albicans 1 cm. 1 cm. 1.5 cm. 1 cm. 
Rhizopus spp. 1.6 cm. 1.5 cm. 1.3 cm. 1 cm. 
Mucur spp. 1.5 cm. 0.7 cm. 1.1 cm. Resistance 
Curvularia lunata 0.2 cm. 0.4 cm. 0.4 cm. 1.2 cm. 
                      CC =Clotrimazole,  KT =Ketoconazole, IT =Itraconazole, AmpB =Amphotericin B 
 
 
 
Fig 1. Photograph of Candida sp. in blood sample and microscopic view of Curvularia sp. 
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Fig 2. Photograph of antibiotic susceptibility test       
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